Nu-Med Plus, Inc. (NUMD)
- Previous Close
0.0373 - Open
0.0400 - Bid --
- Ask --
- Day's Range
0.0400 - 0.0400 - 52 Week Range
0.0116 - 0.0900 - Volume
50,030 - Avg. Volume
46,042 - Market Cap (intraday)
3.342M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Aug 8, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. The company develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications, as well as portable delivery system. It serves hospitals, health systems, and the medical community. The company was incorporated in 2011 and is based in Port Jefferson, New York.
www.nu-medplus.comRecent News: NUMD
Performance Overview: NUMD
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NUMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NUMD
Valuation Measures
Market Cap
3.34M
Enterprise Value
3.44M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-209.55%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-119.15k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
6.36k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.99k